Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 2,404 business days late.
The 37 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 275,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 560,888 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 51,999 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 27,174 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 16,499 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 26,249 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 16,499 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 13,249 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 11,749 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS◆ | 7,949 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 67,498 | $221.50 | $15M | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 2,379 | $221.50 | $526.9K | -100.0% | Open the original filing on SEC.gov |
| Jan 7 | CDTX | Cidara Therapeutics, Inc. | DTOISS | 5,763 | $221.50 | $1.3M | -100.0% | Open the original filing on SEC.gov |
| Dec 22, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 5,425 | — | — | -7.7% | Open the original filing on SEC.gov |
| Dec 19, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 10,638 | — | — | +17.8% | Open the original filing on SEC.gov |
| Dec 19, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 10,638 | — | — | -50.8% | Open the original filing on SEC.gov |
| Dec 17, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 2,244 | — | — | +3.9% | Open the original filing on SEC.gov |
| Dec 17, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 2,244 | — | — | -9.7% | Open the original filing on SEC.gov |
| Dec 10, 2025 | CDTX | Cidara Therapeutics, Inc. | FTAX | 2,285 | $219.60 | $501.8K | -3.9% | Open the original filing on SEC.gov |
| Dec 10, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 33,072 | — | — | +134.5% | Open the original filing on SEC.gov |
| Dec 10, 2025 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 33,072 | — | — | -58.9% | Open the original filing on SEC.gov |
| Jun 24, 2025 | IDYA | IDEAYA Biosciences, Inc. | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2021 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 937 | — | — | +65.0% | Open the original filing on SEC.gov |
| Dec 31, 2021 | CDTX | Cidara Therapeutics, Inc. | GGIFT | 1,873 | — | — | -2.7% | Open the original filing on SEC.gov |
| Dec 10, 2020 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 658 | — | — | -31.3% | Open the original filing on SEC.gov |
| Nov 10, 2020 | CDTX | Cidara Therapeutics, Inc. | PBUY | 2,500 | $40.01 | $100K | +3.7% | Open the original filing on SEC.gov |
| Nov 10, 2020 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 2,500 | $40.01 | $100K | -30.3% | Open the original filing on SEC.gov |
| Sep 12, 2017 | CDTX | Cidara Therapeutics, Inc. | PBUY | 367 | $135.80 | $49.8K | +0.5% | Open the original filing on SEC.gov |
| Sep 12, 2017 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 367 | $135.80 | $49.8K | -4.3% | Open the original filing on SEC.gov |
| Jun 5, 2017 | CDTX | Cidara Therapeutics, Inc. | PBUY | 750 | $118.95 | $89.2K | +1.1% | Open the original filing on SEC.gov |
| Jun 5, 2017 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 750 | $118.95 | $89.2K | -8.0% | Open the original filing on SEC.gov |
| Mar 31, 2017 | CDTX | Cidara Therapeutics, Inc. | PBUY | 645 | $155.00 | $100K | +1.0% | Open the original filing on SEC.gov |
| Mar 31, 2017 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 645 | $155.00 | $100K | -6.4% | Open the original filing on SEC.gov |
| May 23, 2016 | CDTX | Cidara Therapeutics, Inc. | JOTHER | 270 | — | — | -2.6% | Open the original filing on SEC.gov |